Revive to use Ehave Connect to manage patient data
2018-03-01 09:40 ET – News Release
Mr. Craig Leon reports
REVIVE THERAPEUTICS AND EHAVE ENTER INTO PATIENT RESEARCH DATA COLLABORATION AGREEMENT FOR MEDICAL CANNABIS LIVER DISEASE PROGRAM
Revive Therapeutics Ltd. and Ehave Inc., a health care company dedicated to empowering the mental health community with next-generation digital solutions, have entered into a collaboration agreement to enable enhanced patient and clinical research data management for Revive’s research initiatives involving medical cannabis for the treatment of liver diseases.
The collaboration agreement will leverage Ehave’s core expertise in health informatics through its Ehave Connect platform. Revive will integrate the Ehave Connect solution of diagnostic and treatment tools with its continuing research initiatives in liver disease to improve the lives of patients. Ehave Connect will collect and integrate patient data from clinical systems, licensed health surveys, and Ehave’s own patient-reported and clinician-reported outcome applications, empowering users with an end-to-end patient management solution, allowing for better treatment decisions across teams and disciplines while keeping patients informed and engaged throughout their health care journey.
« We are very excited with our collaboration with Ehave as it provides us with a foundation of employing next-generation patient and clinical research data management solutions early on in the research and development phase of our liver disease program, » said Craig Leon, chief executive officer of Revive. « Ehave’s platform will support our research and clinical decisions, and it will allow us to make objective, data-driven decisions throughout the course of our research and may provide unique insights to expand our initiatives with cannabinoids for the potential treatment of liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and fibrosis. »
« Our collaboration with Revive is an important step toward realizing Ehave’s broader goal of partnering with the health care community (and, in particular, companies advancing novel medical cannabis products) to facilitate clinical trials and patient management with a single easy-to-use, end-to-end data informatics platform, » stated Prateek Dwivedi, president and chief executive officer of Ehave. « Not only will this collaboration help to streamline Revive’s research and clinical programs, but it also stands to further establish Ehave’s position as a leader in the health informatics space. »
About Revive Therapeutics Ltd.
Revive Therapeutics is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid-based pharmaceutical markets.